Plain-English translation of NCT07711821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Heart failure is a common condition that many people don't know they have until it becomes serious. This trial is testing whether two new diagnostic tools — a quick ultrasound of your heart and a simple blood test — can help doctors catch heart failure earlier when it's easier to treat. The study will compare patients who receive these new tools along with standard care to those who receive standard care alone.
Many people with heart failure don't get diagnosed or treated early enough, which means they may suffer unnecessary symptoms and complications. This study wants to see if these quick, simple tests can help doctors find heart failure sooner so patients can start treatment earlier and feel better.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four groups: standard care only, standard care plus a blood test, standard care plus an ultrasound scan of your heart, or standard care plus both tests. Depending on your group, you may receive a quick heart ultrasound (which takes just a few minutes) and a simple blood draw at your primary care doctor's office. You will be followed for 12 months with periodic check-ins to assess how you're doing and whether any new treatments have helped improve your quality of life.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
Portugal